Mylan (India)

In this paper, we present the design, implementation and the authentication of a novel Internet of Things (IoT) Anaesthesia drug control system for the online continuous and mutinous controlling of Anaesthesia drugs by detecting two vital body parameters, i.e., body temperature and pulse rate. The mentioned complete system comprises a NodeMCU based control system that drives and reads out the signal from the sensors. When the sensors sense readings of heart rate, body temperature and sweat from the patient's body, which are out of the normal range, the system is designed to drive the servomotor and hence control the Anaesthesia drugs injection in the body according to the patient's current state. The IoT network is upheld by a Cloud framework, which permits the specialist to monitor all the patient's information through Ubidots Cloud. The real time readings of the body parameters of the patient and the position of servo motor, hence the status of the Anaesthesia drug delivery is sent to the hospital cloud from where an anesthetist can observe the readings. If abnormal body temperature and heart rate is observed, the concerned personnel are alerted. Anaesthesia delivery is stopped until the state of the patient becomes normal. The approval closes with the check that this framework effectively works for the concurrent observing and controlling of sedation and the system is turned off manually with a switch. This work is focused on automating the process of Anaesthesia delivery and making the process more economical and efficient.

A series of novel α-aminophosphonates of diethyl (2,4-difluorobenzylamino)methylphosphonate derivatives (4a–4g) have been synthesized by applying three-component Kabachnik–Fields reaction, using fluoro derivatives of aldehydes and substituted amines, diethyl phosphonate in the presence of a catalytic amount of methanesulfonic acid (MSA) in good yields with high enantioselectivities (up to 98% ee). The enantioselectivitiy of compounds (4a–4g) was confirmed by chiral HPLC. The direct Kabachnik–Fields reaction with high reactivity under mild reaction conditions and significantly used for synthesis of the α-aminophosphonate. The novel products were characterized by spectral and analytical data.

Introduction: The present study aims at evaluating anti oxidant activity and inhibition of topical application of Terminalia chebula cream inultraviolet –B-induced psoriasis in rats.Materials and Methods: The seeds of Terminalia chebula were dried and powder was extracted with chloroform, ethyl acetate, ethanol,methanol, and deionized water by cold maceration method. Total phenolic content, total tannin content and total triterpenoid content wasdetermined by different methods. Anti oxidant activity was evaluated by DPPH method and reducing power assay. Cream formulation of theoptimized extract was prepared by hot fusion method. Psoriasis was induced by irradiatiating for 30 min at a vertical distance of 20 cm withUV light (385 nm) on the skin. Severity index, hydroxyproline content and epidermal thickness was determined.Results: Total Phenol (mg gallic acid/ g) content, Total Tannins (mg catechin/ g) content and Total triterpenoid (mg ursolic acid/ g) contentwas found to be significant for water extract.The reducing ability of water extract was always higher than methanol extract at all theconcentrations.Conclusion: We concluded that cream containing 0.1% water extract of Terminalia chebula seeds possess antioxidant activity along withpotent antipsoriatic activity. Further, the application of Terminalia chebula cream resulted in decrease in relative epidermal thickness of animalskin as well as other histopathological features. The present investigation aims at the development of potent phytomedicine for treatment ofpsoriasis from the Terminalia chebula plant.

Abstract A green, straightforward, and efficient protocol for the synthesis of a new series of isoxazolyl chromeno[2, 3‐ b ]pyridine‐3‐carboxylate derivatives have been reported by one‐pot reaction of isoxazolyl enamino esters and 3‐formylchromones by employing water as a reaction medium and polyethylene glycol‐400 (PEG‐400) as the green promoter. The superiority of this protocol is environmentally benign, simple operation, metal‐free, broad substrate scope, good yields, less reaction time and PEG‐400 can be recovered and reused. Most significant of all, this protocol is green.

Dextromethorphan, an anti tussive drug belongs to the morphinan family, and is mostly available in the market as a combination therapy. Most of the reported preparation procedures involve the use of racemic starting materials that give lower yields. (S)- Octa base is one of the key starting raw materials used in our process and this easy, convenient and eco-friendly preparation (single step) is reported in this manuscript. This drug, Dextromethorphan is produced in large volumes annually (> 150 tons/year). Most reported synthetic procedures make use of huge amounts of volatile organic solvents which are hazardous for environment. This will be a major issue in the near future. To overcome this problem, we have tried using Ionic liquid as a solvent in the preparation and successfully arrived at best results, thereby decreasing the use of organic volatile solvents.

The Parenteral Drug Association (PDA) has identified 11 current questions related to data management and control that have been frequently cited in U.S. Food and Drug Administration (FDA) inspections or have led to FDA regulatory actions. The purpose of this document is to help to clarify some of these issues for industry and to help facilitate better compliance by sharing PDA members' expertise in and understanding of current best practices.Data integrity inspectional observations by health authorities can have a severe impact on a firm from a regulatory and public perception perspective and should not result from a lack of clarity by industry about what is required. In addition, firms are concerned that the inability to produce a requested record or document during an inspection, even if not a standard report or existing quality system document, could be construed as delaying, denying, limiting, or refusing inspection, which also has significant consequences.The PDA acknowledges it may not be possible for a single firm or site to have a meaningful discussion of these issues in the context of an inspection or inspection response and is offering these best practices so that industry can proactively comply and properly prioritize its efforts to improve document management and control and good manufacturing practices in the most efficient and effective means possible. The PDA acknowledges there are many more questions to be addressed and hopes that there can be an ongoing dialogue between industry and regulators to facilitate answers.

ABSTRACTIn the present study 12 impurities of bisoprolol fumarate (BISO) and hydrochlorothiazide (HCTZ) were separated simultaneously in a single HPLC method. Out of these 12 impurities, five are potential degradants, which are validated as per The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. As the two active drug substances BISO and HCTZ have different solubilities and polarities, the most critical parameters in resolving the components from each other are pH, temperature, and solvents. The method is precise (RSD < 1.0%), accurate, linear (r2 > 0.999), robust, and stability indicating in the range of limit of quantification (LOQ) to 150%. The HPLC method is then migrated to ultra-performance liquid chromatography (UPLC) to further reduce the run time and solvent consumption, and increase the sample throughput.